基本信息
浏览量:3
职业迁徙
个人简介
RESEARCH INTERESTS
We use human genetics and functional studies in cells and ciliate organisms to understand the molecular genetic basis of ciliopathies, with particular focus on the motile ciliopathies (primary ciliary dyskinesia) and skeletal ciliopathies (Jeune syndrome, short rib thoracic dysplasias). Human cilia and sperm play diverse roles essential to many aspects of normal development and ciliopathies are an expanding group of >20 genetic disorders. Motile cilia dysfunction arising from cilia gene mutations causes a chronic respiratory disease associated with organ asymmetry, infertility and rare neurological symptoms. Dysfunction of primary (sensory) cilia can affect many critical signalling pathways, causing a spectrum of developmental conditions e.g. skeletal dysplasia, retinal degeneration, cystic kidney disease. Mutations in cilia proteins thus underlie a spectrum of complex, multisystem syndromic disorders, that collectively affect more than 1 in 1,000 people.
Through patient sequencing we have determined gene mutations causing human ciliopathy conditions, revealing the cellular protein networks essential to ciliated airway epithelium differentiation and the motility of human sperm and cilia. These include mullticiliogenesis regulators, a chaperone-mediated network of dynein assembly factors and multiple dynein assembly and cilia transport proteins. To help improve disease understanding and guide future clinical management and interventions, we are part of a pan-Europe clinical programme to document all human variants causing motile ciliopathies and the genotype-phenotype correlations that determine how a patient’s underlying genetics affect their clinical disease expression. .
Ciliopathies are incurable disorders affecting all ages of people and from earliest life. We are now translating our biological advances into an improved understanding of disease for the benefit to the affected patients, and developing new genetic medicines to accurately treat ciliopathy patients according to their underlying gene defect. We are currently testing RNA based drugs that correct different classes of mutations causing motile ciliopathy disease.
We use human genetics and functional studies in cells and ciliate organisms to understand the molecular genetic basis of ciliopathies, with particular focus on the motile ciliopathies (primary ciliary dyskinesia) and skeletal ciliopathies (Jeune syndrome, short rib thoracic dysplasias). Human cilia and sperm play diverse roles essential to many aspects of normal development and ciliopathies are an expanding group of >20 genetic disorders. Motile cilia dysfunction arising from cilia gene mutations causes a chronic respiratory disease associated with organ asymmetry, infertility and rare neurological symptoms. Dysfunction of primary (sensory) cilia can affect many critical signalling pathways, causing a spectrum of developmental conditions e.g. skeletal dysplasia, retinal degeneration, cystic kidney disease. Mutations in cilia proteins thus underlie a spectrum of complex, multisystem syndromic disorders, that collectively affect more than 1 in 1,000 people.
Through patient sequencing we have determined gene mutations causing human ciliopathy conditions, revealing the cellular protein networks essential to ciliated airway epithelium differentiation and the motility of human sperm and cilia. These include mullticiliogenesis regulators, a chaperone-mediated network of dynein assembly factors and multiple dynein assembly and cilia transport proteins. To help improve disease understanding and guide future clinical management and interventions, we are part of a pan-Europe clinical programme to document all human variants causing motile ciliopathies and the genotype-phenotype correlations that determine how a patient’s underlying genetics affect their clinical disease expression. .
Ciliopathies are incurable disorders affecting all ages of people and from earliest life. We are now translating our biological advances into an improved understanding of disease for the benefit to the affected patients, and developing new genetic medicines to accurately treat ciliopathy patients according to their underlying gene defect. We are currently testing RNA based drugs that correct different classes of mutations causing motile ciliopathy disease.
研究兴趣
论文共 226 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF HEALTH PSYCHOLOGYpp.13591053231223912-13591053231223912, (2024)
BMJ Openno. Suppl 1 (2024)
Daniel O Dodd, Sabrina Mechaussier,Patricia L Yeyati,Fraser McPhie,Jacob R Anderson, Chen Jing Khoo,Amelia Shoemark, Deepesh K Gupta,Thomas Attard,Maimoona A Zariwala,Marie Legendre,Diana Bracht,
Oriane Grant, Isobel Larken, Sam Reitemeier,Hannah M Mitchison, William Dawes, Angus Phillips,Mario Cortina-Borja,Claire Mary Smith
biorxiv(2023)
引用0浏览0引用
0
0
引用0浏览0WOS引用
0
0
Suzanne Crowley,William Hankey,Marwa Elnagheeb,Rahma Mani, Maria-Ines Benito, Rasha Soliman, Mafalda De Almeida Gomes, Alexander Ing, Sabri Abdelwahab, Lindsay Worley,Shannon Mcnulty, Justine Siew,
EUROPEAN RESPIRATORY JOURNAL (2023)
Deborah Morris-Rosendahl,Andrew Fleming,Miranda Galey, Lizi Briggs,Claire Hogg,Matthew Edwards,Shibu John,Sam Wilkinson,Ellie Quinn,Ranjit Rai,Tom Burgoyne, Andy Rogers,
EUROPEAN RESPIRATORY JOURNAL (2023): 1-12
medRxiv : the preprint server for health sciencesno. 6 (2023): e1010796-e1010796
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn